Prof. Lea Ann Dailey is a University Professor and Deputy Head of the Department of Pharmaceutical Sciences at the University of Vienna. Her research focuses on nanomedicine, pharmaceutical biophysics, and respiratory drug delivery. She leads projects like Imptox (studying nanoplastic toxicity) and ANTI-TB (targeting tuberculosis via inhalable nanocarriers). Her work involves advanced techniques like AFM-IR and X-ray analysis, with collaborations across Europe. She teaches courses on pharmaceutical technology, magistral formulae, and drug discovery. Her lab uses state-of-the-art equipment including BSL2 facilities and Next Generation Impactors. Current research spans nanoplastic environmental impacts, anti-infective formulations, and high-entropy nanozymes for diagnostics. Projects are funded by EU Horizon 2020 and German BMBF grants. Education details are not explicitly listed, but her professional trajectory indicates extensive academic training in pharmacy and biophysics. She advises on tuberculosis drug delivery and lipid nanotechnology, with over 50 peer-reviewed publications. Her lab's work bridges fundamental biophysics with translational drug delivery solutions, emphasizing inhaled therapies for chronic respiratory infections.








